Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD 371 in Healthy Subjects
Status:
Not yet recruiting
Trial end date:
2022-11-20
Target enrollment:
Participant gender:
Summary
This study is an open-label, randomized, single dose, crossover study to evaluate the
pharmacokinetics, safety and tolerability of CKD-388 in healthy subjects